Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)
| 0.3199 Delayed Data As of 3:59pm ET |  +0.0199 / +6.63%Today’s Change | 0.30 Today|||52-Week Range 2.73 | -82.42% Year-to-Date |
Latest GLMD News | Press Releases
No recent news for Galmed Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 0.30 |
| Today’s open | 0.32 |
| Day’s range | 0.32 - 0.32 |
| Volume | 72 |
| Average volume (3 months) | 60,392 |
| Market cap | $7.6M |
Data as of 3:59pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -94,178.57% |
| Earnings growth (this year) | +43.43% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NBSENeuBase Therapeutics... | 0.00 | 0.00% |
| ADILAdial Pharmaceutical... | 0.00 | 0.00% |
| ---- | ||
| AGRXAgile Therapeutics I... | -0.00 | -0.76% |
Data as of 3:57pm ET, 11/28/2022
Financials
| Last reporting date | November 28, 2022 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
Chart unavailable
